Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Cash Flow Per Share

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY.

The item "Cash-Flow-Per-Share" stands at 719.75 Japanese Yens as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Cash Flow Per Share" stands at 719.75 JPY. This represents an increase of 11.25 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 41.90 percent compared to the value the year prior.
The 1 year change in percent is 41.90.
The 3 year change in percent is 22.64.

The Serie's long term average value is 584.20 Japanese Yens. It's latest available value, on 09/30/2025, is 23.20 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +66.80%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Cash Flow Per Share for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash Flow Per Share905,699,262,464.00
LogoJohnson & Johnson - Cash Flow Per Share486,508,953,600.00
LogoAbbVie Inc - Cash Flow Per Share399,570,305,024.00
LogoRoche Holding AG - Cash Flow Per Share317,433,206,677.55
LogoAstraZeneca PLC - Cash Flow Per Share280,205,508,085.11